Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Mar 2026 for Intellia Therapeutics, Inc..
Filing timeline
BuySaleBirgit C. Schultes
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Birgit C. Schultes: trading record in brief
Birgit C. Schultes is a declared insider of Intellia Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 1 March 2025 and 1 March 2026, the trades on record add up to 4 filings.
The open-market record consists of 2 sales worth €67k, with no purchase. Other entries cover 2 share grants. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 3 March 2026: a share grant, in Intellia Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Birgit C. Schultes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
39,200 shares0Common StockSEC:0001193125-26-088251:0
8,508 shares@ US$9.2199.3% of flowCommon StockSEC:0001193125-26-006292:0
31 shares@ US$17.380.7% of flowCommon StockSEC:0001193125-25-230424:0
37,600 shares0Common StockSEC:0000950170-25-032101:0
4 of 4 declarations
